Completed |
: Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
: - Lymphoma, Non-Hodgkin
- HIV Infections
: 1999-11-02
: - Drug: Mitoxantrone hydrochloride
- Drug: Eto
|
Active, not recruiting |
: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
: - Burkitt Lymphoma
- Diffuse Large B-cell Lymphoma, c-MYC Positive
-
- Drug: EPOCH-R EPOCH-R every 21
|
Completed |
: Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (BMT CTN 0401)
: - Lymphoma, B-Cell
- Lymphoma, Large-Cell, Immunoblastic
: 2006-05-22
: - Drug: Autologous transplantation using rituxan/BEAM
|
Completed |
: Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
: - AIDS-related Diffuse Large Cell Lymphoma
- AIDS-related Immunoblastic La
: 2002-11-12
: - Biological: rituximab Given IV
|
Recruiting |
: Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
: - AIDS-related Non-Hodgkin Lymphoma
- AIDS-related Plasmablastic Lymphoma<
: 2013-09-09
:
|
Completed |
: Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
: Lymphoma
: 1999-11-01
: - Biological: bleomycin sulfate
- Drug: CHOP r
|
Completed |
: A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma
: Untreated T-cell Angioimmunoblastic Lymphoma
: 2005-09-12
: - Drug: Rituximab 375 mg/m2 D1
|
Not yet recruiting |
: Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
: - Adult Burkitt Lymphoma
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between D
: 2015-05-26
: - Drug: Cyclophosphamide Given I
|
Active, not recruiting |
: Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
: - Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- Previously Treated Myelodysplast
: 2005-03-03
: - Drug: Fludarabine Phosphate Gi
|
Completed |
: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
: - Accelerated Phase Chronic Myelogenous Leukemia
- Acute Undifferentiated Leukemia
: 2005-06-02
: - Drug: fludarabine phosphate Gi
|